Jacobs & Co/ca reports 3.08% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock) - 13F, 13D, 13G Filings

Novartis AG - Depositary Receipt (Common Stock)

DE ˙ DB ˙ US66987V1098

121,00 € 0,00 (0,00%)

2026-06-04
DELAT PRIS

Security	DE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
Institution	Jacobs & Co/ca
Latest Disclosed Ownership	2,520 shares
Latest Disclosed Value	$ 384

Jacobs & Co/ca reports 3.08% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 7, 2026 - Jacobs & Co/ca filed a 13F-HR form disclosing ownership of 2,520 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $323,820 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 5, 2026 disclosing 2,600 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $304,920 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-07	2026-03-31	13F	Novartis AG ADR	CLB	66987V109	2,520	-80	-3.08	0		0.0379
2026-01-05	2025-12-31	13F	NovartisAGADR	CLB	66987V109	2,600	0	0.00	0		0.0338
2025-10-01	2025-09-30	13F	Novartis AG ADR	CLB	66987V109	2,600	0	0.00	0		0.0319
2025-07-02	2025-06-30	13F	Novartis AG ADR	CLB	66987V109	2,600	0	0.00	0		0.0312
2025-04-03	2025-03-31	13F	NovartisAGADR	CLB	66987V109	2,600	-150	-5.45	0		0.0308
2025-01-10	2024-12-31	13F	NovartisAGADR	CLB	66987V109	2,750	0	0.00	0		0.0272
2024-10-01	2024-09-30	13F	Novartis AG ADR	CLB	66987V109	2,750	0	0.00	0		0.0316
2024-07-12	2024-06-30	13F	Novartis	CLB	66987V109	2,750	0	0.00	0		0.0306
2024-04-12	2024-03-31	13F	NovartisAG	CLB	66987V109	2,750	-225	-7.56	0		0.0282
2024-01-18	2023-12-31	13F	NovartisAG	CLB	66987V109	2,975	150	5.31	0		0.0340
2023-10-13	2023-09-30	13F	NovartisAG	ADR	66987V109	2,825	0	0.00	0		0.0358
2023-07-11	2023-06-30	13F	Novartis	ADR	66987V109	2,825	0	0.00	0		0.0339
2023-04-17	2023-03-31	13F	Novartis	ADR	66987V109	2,825	0	0.00	0		0.0320
2023-01-13	2022-12-31	13F	Novartis	ADR	66987V109	2,825	0	0.00	0	-100.00	0.0333
2022-10-11	2022-09-30	13F	Novartis	ADR	66987V109	2,825	0	0.00	214	-10.08	0.0308
2022-07-19	2022-06-30	13F	Novartis	ADR	66987V109	2,825	-1,500	-34.68	238	-37.20	0.0319
2022-04-14	2022-03-31	13F	Novartis	ADR	66987V109	4,325	-1,000	-18.78	379	-18.49	0.0420
2022-01-21	2021-12-31	13F	Novartis	ADR	66987V109	5,325	0	0.00	465	6.90	0.0482
2021-10-13	2021-09-30	13F	Novartis	ADR	66987V109	5,325	0	0.00	435	-10.31	0.0500
2021-07-15	2021-06-30	13F	Novartis	ADR	66987V109	5,325	600	12.70	485	20.35	0.0560
2021-04-05	2021-03-31	13F	Novartis	ADR	66987V109	4,725	0	0.00	403	-9.64	0.0493
2021-01-12	2020-12-31	13F	Novartis	ADR	66987V109	4,725	0	0.00	446	8.78	0.0579
2020-12-03	2020-09-30	13F	Novartis	ADR	66987V109	4,725	0	0.00	410	-0.49	0.0595
2020-07-09	2020-06-30	13F	Novartis	ADR	66987V109	4,725	0	0.00	412	5.91	0.0671
2020-04-13	2020-03-31	13F	Novartis A G Spon Adr	ADR	66987V109	4,725	0	0.00	389	-12.98	0.0751
2020-01-29	2019-12-31	13F	Novartis A G Spon Adr	SPON ADR	66987V109	4,725	1,500	46.51	447	59.64	0.0679
2019-11-04	2019-09-30	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,225	0	0.00	280	-4.76	0.0454
2019-08-01	2019-06-30	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,225	0	0.00	294	-5.16	0.0475
2019-04-29	2019-03-31	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,225	-250	-7.19	310	4.03	0.0528
2019-02-07	2018-12-31	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,475	0	0.00	298	-0.33	0.0587
2018-10-23	2018-09-30	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,475	0	0.00	299	14.12	0.0506
2018-07-19	2018-06-30	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,475	0	0.00	262	-6.43	0.0474
2018-04-27	2018-03-31	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,475	0	0.00	280	-3.78	0.0517
2018-02-09	2017-12-31	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,475	0	0.00	291	-2.35	0.0526
2017-11-14	2017-09-30	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,475	-500	-12.58	298	-9.97	0.0560
2017-07-13	2017-06-30	13F	Novartis A G Spon Adr	SPON ADR	66987V109	3,975	-250	-5.92	331	5.75	0.0652
2017-04-12	2017-03-31	13F	Novartis A G Spon Adr	SPON ADR	66987V109	4,225	-1,000	-19.14	313	-17.63	0.0643
2017-01-18	2016-12-31	13F	Novartis A G Spon Adr	SPON ADR	66987V109	5,225	-455	-8.01	380	-15.18	0.0824
2016-10-11	2016-09-30	13F	Novartis A G Spon Adr	SPON ADR	66987V109	5,680	0	0.00	448	-4.27	0.0999
2016-07-08	2016-06-30	13F	Novartis A G Spon Adr	SPON ADR	66987V109	5,680	0	0.00	468	13.87	0.1099
2016-04-14	2016-03-31	13F	Novartis A G Spon Adr	SPON ADR	66987V109	5,680	0	0.00	411	-11.99	0.0989
2016-01-14	2015-12-31	13F	Novartis A G Spon Adr	ADR	66987V109	5,680	-420	-6.89	467	-16.61	0.1210
2015-10-15	2015-09-30	13F	Novartis A G Spon Adr	COM	66987V109	6,100	-500	-7.58	560	-13.71	0.1487
2015-07-02	2015-06-30	13F	Novartis A G Spon Adr	COM	66987V109	6,600	-1,145	-14.78	649	-14.94	0.1624
2015-04-07	2015-03-31	13F	Novartis A G Spon Adr	COM	66987V109	7,745	-275	-3.43	763	2.69	0.1932
2015-03-10	2014-12-31	13F	Novartis A G Spon Adr	COM	66987V109	8,020	0	0.00	743	-1.59	0.1956
2014-10-07	2014-09-30	13F	Novartis A G Spon Adr	COM	66987V109	8,020	0	0.00	755	3.99	0.2135
2014-07-16	2014-06-30	13F/A-1	Novartis A G Spon Adr	COM	66987V109	8,020	-460	-5.42	726	0.69	0.2104
2014-07-15	2014-06-30	13F	Novartis A G Spon Adr	COM	66987V109	8,020			726
2014-04-22	2014-03-31	13F	Novartis A G Spon Adr	COM	66987V109	8,480	1,000	13.37	721	19.97	0.2236
2014-01-27	2013-12-31	13F	Novartis A G Spon Adr	COM	66987V109	7,480	0	0.00	601	4.89	0.1923
2013-10-09	2013-09-30	13F	Novartis A G Spon Adr	COM	66987V109	7,480	-1,200	-13.82	573	-6.53	0.1992
2013-07-19	2013-06-30	13F	Novartis A G	ADR	66987V109	8,680	8,680		613		0.2221

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.